Clinical trial
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients
NCT03048266 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 5, 2015
- Completion date
- November 1, 2026
- Enrollment
- 629 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.